India is seeking a larger role in multinational clinical research, and the argument is increasingly about more than cost. In a recent interview with Pharma Industrial India, Dr. Seema Pai, President of the Indian Society for Clinical Research (ISCR), described India’s growing ambitions in global clinical trials. Her comments focused...
FDA Launches Review of Clinical Trials Sending U.S. Genetic Material to China
The U.S. Food and Drug Administration has announced an immediate review of clinical trials that involve the transfer of American citizens' living cells to China and other hostile countries for genetic engineering. This urgent action comes amid increasing concerns that trial participants may not have been fully informed about the...
India Hopes to Accelerate Approval of New Drugs
The Indian government has designated the Central Drugs Standard Control Organisation (CDSCO) as the first point of registration for clinical trials of all drugs and vaccines, a move expected to cut the approval time to three months from 12 months, according to the Economic Times. The cabinet secretary-led panel has...